The PI3K-d Inhibitor TGR-1202 in Combination with Brentuximab Vedotin (SGN-35) Synergistically Induces G2/M Phase Arrest and Cell Death Via Inhibition Of Tubulin Polymerization in Hodgkin Lymphoma Cell Lines.

Drug Category: Array
Conference Category: Array
Lead Author: Locatelli S, Carlo-Stella C, et al.
Published Date: 10/12/2013
Download Link: /wp-content/uploads/2020/05/Locatelli-ASH2013Poster1835.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top